BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36125123)

  • 1. FSH-blocking therapeutic for osteoporosis.
    Gera S; Kuo TC; Gumerova AA; Korkmaz F; Sant D; DeMambro V; Sudha K; Padilla A; Prevot G; Munitz J; Teunissen A; van Leent MMT; Post TGJM; Fernandes JC; Netto J; Sultana F; Shelly E; Rojekar S; Kumar P; Cullen L; Chatterjee J; Pallapati A; Miyashita S; Kannangara H; Bhongade M; Sengupta P; Ievleva K; Muradova V; Batista R; Robinson C; Macdonald A; Hutchison S; Saxena M; Meseck M; Caminis J; Iqbal J; New MI; Ryu V; Kim SM; Cao JJ; Zaidi N; Fayad ZA; Lizneva D; Rosen CJ; Yuen T; Zaidi M
    Elife; 2022 Sep; 11():. PubMed ID: 36125123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and biophysical characterization of a humanized FSH-blocking monoclonal antibody therapeutic formulated at an ultra-high concentration.
    Rojekar S; Pallapati AR; Gimenez-Roig J; Korkmaz F; Sultana F; Sant D; Haeck CM; Macdonald A; Kim SM; Rosen CJ; Barak O; Meseck M; Caminis J; Lizneva D; Yuen T; Zaidi M
    Elife; 2023 Jun; 12():. PubMed ID: 37334968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Biophysical Characterization of a Humanized FSH-Blocking Monoclonal Antibody Therapeutic Formulated at an Ultra-High Concentration.
    Rojekar S; Pallapati AR; Gimenez-Roig J; Korkmaz F; Sultana F; Sant D; Haeck C; Macdonald A; Kim SM; Rosen CJ; Barak O; Meseck M; Caminis J; Lizneva D; Yuen T; Zaidi M
    bioRxiv; 2023 May; ():. PubMed ID: 37214886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing a therapeutic humanized follicle-stimulating hormone-blocking antibody formulation by protein thermal shift assay.
    Sant D; Rojekar S; Gera S; Pallapati AR; Gimenez-Roig J; Kuo TC; Padilla A; Korkmaz F; Cullen L; Chatterjee J; Shelly E; Meseck M; Miyashita S; Macdonald A; Sultana F; Barak O; Ryu V; Kim SM; Robinson C; Rosen CJ; Caminis J; Lizneva D; Haider S; Yuen T; Zaidi M
    Ann N Y Acad Sci; 2023 Mar; 1521(1):67-78. PubMed ID: 36628526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-in-class humanized FSH blocking antibody targets bone and fat.
    Gera S; Sant D; Haider S; Korkmaz F; Kuo TC; Mathew M; Perez-Pena H; Xie H; Chen H; Batista R; Ma K; Cheng Z; Hadelia E; Robinson C; Macdonald A; Miyashita S; Williams A; Jebian G; Miyashita H; Gumerova A; Ievleva K; Smith P; He J; Ryu V; DeMambro V; Quinn MA; Meseck M; Kim SM; Kumar TR; Iqbal J; New MI; Lizneva D; Rosen CJ; Hsueh AJ; Yuen T; Zaidi M
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28971-28979. PubMed ID: 33127753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FSH-metabolic circuitry and menopause.
    Taneja C; Gera S; Kim SM; Iqbal J; Yuen T; Zaidi M
    J Mol Endocrinol; 2019 Oct; 63(3):R73-R80. PubMed ID: 31454787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope-specific monoclonal antibodies to FSHβ increase bone mass.
    Ji Y; Liu P; Yuen T; Haider S; He J; Romero R; Chen H; Bloch M; Kim SM; Lizneva D; Munshi L; Zhou C; Lu P; Iqbal J; Cheng Z; New MI; Hsueh AJ; Bian Z; Rosen CJ; Sun L; Zaidi M
    Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2192-2197. PubMed ID: 29440419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FSH blockade improves cognition in mice with Alzheimer's disease.
    Xiong J; Kang SS; Wang Z; Liu X; Kuo TC; Korkmaz F; Padilla A; Miyashita S; Chan P; Zhang Z; Katsel P; Burgess J; Gumerova A; Ievleva K; Sant D; Yu SP; Muradova V; Frolinger T; Lizneva D; Iqbal J; Goosens KA; Gera S; Rosen CJ; Haroutunian V; Ryu V; Yuen T; Zaidi M; Ye K
    Nature; 2022 Mar; 603(7901):470-476. PubMed ID: 35236988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Body weight and bone/calcium metabolism. FSH and obesity, osteoporosis.].
    Endo I
    Clin Calcium; 2018; 28(7):941-945. PubMed ID: 29950547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking FSH induces thermogenic adipose tissue and reduces body fat.
    Liu P; Ji Y; Yuen T; Rendina-Ruedy E; DeMambro VE; Dhawan S; Abu-Amer W; Izadmehr S; Zhou B; Shin AC; Latif R; Thangeswaran P; Gupta A; Li J; Shnayder V; Robinson ST; Yu YE; Zhang X; Yang F; Lu P; Zhou Y; Zhu LL; Oberlin DJ; Davies TF; Reagan MR; Brown A; Kumar TR; Epstein S; Iqbal J; Avadhani NG; New MI; Molina H; van Klinken JB; Guo EX; Buettner C; Haider S; Bian Z; Sun L; Rosen CJ; Zaidi M
    Nature; 2017 Jun; 546(7656):107-112. PubMed ID: 28538730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel follicle-stimulating hormone vaccine for controlling fat accumulation.
    Han X; Guan Z; Xu M; Zhang Y; Yao H; Meng F; Zhuo Y; Yu G; Cao X; Du X; Bu G; Kong F; Huang A; Zeng X
    Theriogenology; 2020 May; 148():103-111. PubMed ID: 32171969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary and ovarian expression of the endogenous follicle-stimulating hormone (FSH) subunit genes and an FSH beta-subunit promoter-driven herpes simplex virus thymidine kinase gene in transgenic mice; specific partial ablation of FSH-producing cells by antiherpes treatment.
    Markkula M; Kananen K; Klemi P; Huhtaniemi I
    J Endocrinol; 1996 Aug; 150(2):265-73. PubMed ID: 8869593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New hope for symptom management during natural and iatrogenic menopause transitions.
    Woodruff TK; Khosla S
    Biol Reprod; 2017 Aug; 97(2):177-178. PubMed ID: 29044424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extragonadal Effects of Follicle-Stimulating Hormone on Osteoporosis and Cardiovascular Disease in Women during Menopausal Transition.
    Zhu D; Li X; Macrae VE; Simoncini T; Fu X
    Trends Endocrinol Metab; 2018 Aug; 29(8):571-580. PubMed ID: 29983231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis.
    Zhu LL; Blair H; Cao J; Yuen T; Latif R; Guo L; Tourkova IL; Li J; Davies TF; Sun L; Bian Z; Rosen C; Zallone A; New MI; Zaidi M
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14574-9. PubMed ID: 22908268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of a novel long-acting recombinant follicle stimulating hormone agonist by fusing Fc to an FSH-β subunit.
    Zhang YL; Guo KP; Ji SY; Liu XM; Wang P; Wu J; Gao L; Jiang TQ; Xu T; Fan HY
    Hum Reprod; 2016 Jan; 31(1):169-82. PubMed ID: 26621853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dopamine on the altered release of prolactin, luteinizing hormone, and follicle-stimulating hormone induced by interleukin-2 in vitro.
    Karanth S; Marubayashi U; McCann SM
    Neuroendocrinology; 1992 Dec; 56(6):871-80. PubMed ID: 1369597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacement with recombinant human inhibin immediately after orchidectomy in the hypophysiotropically clamped male rhesus monkey (Macaca mulatta) maintains follicle-stimulating hormone (FSH) secretion and FSH beta messenger ribonucleic acid levels at precastration values.
    Majumdar SS; Mikuma N; Ishwad PC; Winters SJ; Attardi BJ; Perera AD; Plant TM
    Endocrinology; 1995 May; 136(5):1969-77. PubMed ID: 7720645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship between Follicle-stimulating Hormone and Bone Health: Alternative Explanation for Bone Loss beyond Oestrogen?
    Chin KY
    Int J Med Sci; 2018; 15(12):1373-1383. PubMed ID: 30275766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FSH, Bone Mass, Body Fat, and Biological Aging.
    Zaidi M; Lizneva D; Kim SM; Sun L; Iqbal J; New MI; Rosen CJ; Yuen T
    Endocrinology; 2018 Oct; 159(10):3503-3514. PubMed ID: 30085049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.